Cargando…
Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
BACKGROUND: In transplantation, plasmapheresis and IVIg provide the mainstay of treatment directed at reducing or removing circulating donor-specific antibody (DSA), yet both have limitations. We sought to test the efficacy of targeting the IgG recycling mechanism of the neonatal Fc receptor (FcRn)...
Autores principales: | Manook, Miriam, Flores, Walter J., Schmitz, Robin, Fitch, Zachary, Yoon, Janghoon, Bae, Yeeun, Shaw, Brian, Kirk, Allan, Harnois, Melissa, Permar, Sallie, Farris, Alton B., Magnani, Diogo M., Kwun, Jean, Knechtle, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207189/ https://www.ncbi.nlm.nih.gov/pubmed/34149698 http://dx.doi.org/10.3389/fimmu.2021.660900 |
Ejemplares similares
-
Characterization of the Rabbit Neonatal Fc Receptor (FcRn) and Analyzing the Immunophenotype of the Transgenic Rabbits That Overexpresses FcRn
por: Catunda Lemos, Ana Paula, et al.
Publicado: (2012) -
The Role of FcRn in Antigen Presentation
por: Baker, Kristi, et al.
Publicado: (2014) -
The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019) -
The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020) -
Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
por: Zhou, Yihan, et al.
Publicado: (2023)